Selling and marketing expenses increased 10.5% to $3 million, reflecting additional sales resources and higher travel costs.

Aug 4, 2026 / receipt, needs a key / Barry Steele, CFO | earnings call 2026-08-04 | transcript 8ca4139f-4ac0-4421-8672-e207d8e419be | chars 9286-9410 | segment 9

Additional reductions included a $300,000 reduction in accrual for management bonuses, lower accounting fees totaling $200,000, and $100,000 in reduced travel expenses.

May 7, 2026 / receipt, needs a key / Barry, CFO | earnings call 2026-05-07 | transcript 80f49c77-3d66-4b49-9e9e-505b4e1eae6e | chars 5472-5640 | segment 5

The increase also was the result of a one-time 600,000 unfavorable adjustments made in 2024 to correct an immaterial error in our travel accrual.

Aug 5, 2025 / receipt, needs a key / Barry Steele, CFO | earnings call 2025-08-05 | transcript 4cb9e136-d682-4b51-a29d-7790a2a0fbca | chars 11759-11904 | segment 11

What we have is a great network, certainly from our regional perspective as well. The technicians that really aren't traveling as much, they're in specific locations. There's opportunity for additional work even outside of GE, hopefully some additional work there.

May 8, 2025 / receipt, needs a key / Carrie Lee Chance, Chief Operating Officer and incoming CEO | earnings call 2025-05-08 | transcript a5c177f1-c4bf-42f8-98e9-df148c8671f4 | chars 17811-18075 | segment 17

Other contributors to the higher rate include limitations on the deductibility of reimbursed meals for our travel teams and officers' compensation, and impacts for local and foreign income taxes for jurisdictions where we do business.

Mar 4, 2025 / receipt, needs a key / Barry Steele, CFO | earnings call 2025-03-04 | transcript b8543193-5d7b-48f8-ac6e-58a4756de365 | chars 9690-9924 | segment 10

Long-Term Sustainable Target: 22% - 25% Corridor

ir_statement / Sep 15, 2026 / receipt

Multi-year ERP and platform infrastructure costs are rolling off ($2.6M in 2025)

ir_statement / Sep 15, 2026 / receipt

Scaling Revenue Without Scaling Costs

ir_statement / Sep 15, 2026 / receipt

Expanded ambulatory pump platform into pain management therapies

ir_statement / Sep 15, 2026 / receipt

Expanded capabilities in biomedical services, equipment management and distribution

ir_statement / Sep 15, 2026 / receipt

Expanded into NPWT, lymphedema therapy, pneumatic compression devices and advanced wound care products

ir_statement / Sep 15, 2026 / receipt

New therapies added without incremental investment

ir_statement / Sep 15, 2026 / receipt

continued expansion across 1,800+ practices

ir_statement / Sep 15, 2026 / receipt

ERP Complete: Improved billing efficiency

ir_statement / Sep 15, 2026 / receipt

Strategic Contract Optimization: Restructuring profit dollars

ir_statement / Sep 15, 2026 / receipt

Enter additional adjacent therapies using existing clinical, logistics and reimbursement infrastructure

ir_statement / Sep 15, 2026 / receipt

Expand multi-site and enterprise-level agreements with health systems

ir_statement / Sep 15, 2026 / receipt